10x Genomics
338 hedge funds and large institutions have $15.2B invested in 10x Genomics in 2021 Q2 according to their latest regulatory filings, with 66 funds opening new positions, 156 increasing their positions, 76 reducing their positions, and 45 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
7.14% more ownership
Funds ownership: 81.96% → 89.1% (+7.1%)
5% more funds holding
Funds holding: 321 → 338 (+17)
10% less funds holding in top 10
Funds holding in top 10: 10 → 9 (-1)
Holders
338
Holding in Top 10
9
Calls
$86.3M
Puts
$29M
Top Buyers
| 1 | +$712M | |
| 2 | +$439M | |
| 3 | +$156M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$108M |
| 5 |
BCM
Brown Capital Management
Baltimore,
Maryland
|
+$108M |
Top Sellers
| 1 | -$361M | |
| 2 | -$97.9M | |
| 3 | -$77.2M | |
| 4 |
MCAV
Meritech Capital Associates V
Palo Alto,
California
|
-$64.5M |
| 5 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$62.8M |